Gyd Diagnostics And Reference Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 1.67 Cr
as on 06-07-2024
- Company Age 17 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 84.30%
(FY 2022)
- Profit 88039.07%
(FY 2022)
- Ebitda -50.75%
(FY 2022)
- Net Worth 22.25%
(FY 2022)
- Total Assets 27.58%
(FY 2022)
About Gyd Diagnostics And Reference Laboratories
The Corporate was formerly known as Gyd Diagnostics And Laboratories Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.67 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raghu Puskoor, Dinaker Manjunath, Saluja Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110TG2007PTC056624
- Company No.
056624
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Secunderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gyd Diagnostics And Reference Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghu Puskoor  | Director | 11-Dec-2007 | Current |
| Dinaker Manjunath | Director | 11-Dec-2007 | Current |
| Saluja Singh | Director | 11-Dec-2007 | Current |
| Vijay Yeldandi | Director | 11-Dec-2007 | Current |
Financial Performance and Corporate Structure Insights of Gyd Diagnostics And Reference Laboratories.
Gyd Diagnostics And Reference Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 84.3% increase. The company also saw a substantial improvement in profitability, with a 88039.07% increase in profit. The company's net worth Soared by an impressive increase of 22.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gyd Diagnostics And Reference Laboratories?
In 2022, Gyd Diagnostics And Reference Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Manisha Hospitality Services Private LimitedActive 11 years 7 months
Raghu Puskoor is a mutual person
- Suvarna Swasthya Research Centre Private LimitedActive 9 years 5 months
Raghu Puskoor and Vijay Yeldandi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gyd Diagnostics And Reference Laboratories?
Gyd Diagnostics And Reference Laboratories has a workforce of 31 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gyd Diagnostics And Reference Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gyd Diagnostics And Reference Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
